Redhill Biopharma
RDHL
#10222
Rank
โ‚ฌ3.54 M
Marketcap
2,00ย โ‚ฌ
Share price
1.79%
Change (1 day)
-79.96%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): โ‚ฌ6.97 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚ฌ35.74 Million. In 2022 the company made an earning of -โ‚ฌ62.97 Million, an increase over its 2021 earnings that were of -โ‚ฌ85.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚ฌ6.97 M-111.08%
2022 -โ‚ฌ62.97 Million-26.68%
2021 -โ‚ฌ85.88 Million28.32%
2020 -โ‚ฌ66.93 Million80.06%
2019 -โ‚ฌ37.17 Million8.97%
2018 -โ‚ฌ34.11 Million-14.76%
2017 -โ‚ฌ40.02 Million55.07%
2016 -โ‚ฌ25.81 Million39.26%
2015 -โ‚ฌ18.53 Million96.9%
2014 -โ‚ฌ9.42 Million0.78%
2013 -โ‚ฌ9.34 Million16.93%
2012 -โ‚ฌ7.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.97 B 68,531.52%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ18.63 B 183,161.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.86 B 37,875.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ38.41 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚ฌ0.25 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel